139 related articles for article (PubMed ID: 33426063)
1. LHPP Inhibits the Proliferation and Metastasis of Renal Cell Carcinoma.
Zhang X; Kang H; Xiao J; Shi B; Li X; Chen G
Biomed Res Int; 2020; 2020():7020924. PubMed ID: 33426063
[TBL] [Abstract][Full Text] [Related]
2. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients.
Meng K; Li Z; Cui X
J Clin Lab Anal; 2021 Dec; 35(12):e24077. PubMed ID: 34699621
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of LHPP in cervical cancer influences cell proliferation, metastasis and apoptosis by modulating AKT.
Zheng J; Dai X; Chen H; Fang C; Chen J; Sun L
Biochem Biophys Res Commun; 2018 Sep; 503(2):1108-1114. PubMed ID: 29944886
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3.
Chen Y; Zhu Y; Sheng Y; Xiao J; Xiao Y; Cheng N; Chai Y; Wu X; Zhang S; Xiang T
Exp Cell Res; 2019 Sep; 382(2):111466. PubMed ID: 31201813
[TBL] [Abstract][Full Text] [Related]
5. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway.
Sun W; Qian K; Guo K; Chen L; Xiang J; Li D; Wu Y; Ji Q; Sun T; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):382-389. PubMed ID: 32227107
[TBL] [Abstract][Full Text] [Related]
6. LINC01510 suppresses cell proliferation and invasion by inhibiting Wnt/β-catenin signaling in renal cell carcinoma.
Ma B; Zhang J; Zhou W; Chu C; Zhao C; Zhang Z; Huang T
Biochem Biophys Res Commun; 2018 Oct; 505(1):7-12. PubMed ID: 30224058
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
[TBL] [Abstract][Full Text] [Related]
8. The kinesin motor protein KIF4A as a potential therapeutic target in renal cell carcinoma.
Liu G; Lu Y; Li L; Jiang T; Chu S; Hou P; Bai J; Chen M
Invest New Drugs; 2020 Dec; 38(6):1730-1742. PubMed ID: 32533288
[TBL] [Abstract][Full Text] [Related]
9. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
12. MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.
Qin Z; Wei X; Jin N; Wang Y; Zhao R; Hu Y; Yan W; Li J; Zhou Q
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1920-1925. PubMed ID: 29130345
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.
Hou B; Li W; Li J; Ma J; Xia P; Liu Z; Zeng Q; Zhang X; Chang D
Oncol Rep; 2020 Feb; 43(2):536-548. PubMed ID: 31894339
[TBL] [Abstract][Full Text] [Related]
14. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
[TBL] [Abstract][Full Text] [Related]
15. Methylation-mediated miR-214 regulates proliferation and drug sensitivity of renal cell carcinoma cells through targeting LIVIN.
Xu H; Wu S; Shen X; Shi Z; Wu D; Yuan Y; Jiang W; Wang Q; Ke Q; Mao Q; Li X; Liu Y; Yuan P; Zhang Q; Huang E; Chen X
J Cell Mol Med; 2020 Jun; 24(11):6410-6425. PubMed ID: 32395888
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of COUP-TFII inhibits cell proliferation and induces apoptosis through upregulating BRCA1 in renal cell carcinoma cells.
Zheng J; Qin W; Jiao D; Ren J; Wei M; Shi S; Xi W; Wang H; Yang AG; Huan Y; Wen W
Int J Cancer; 2016 Oct; 139(7):1574-85. PubMed ID: 27193872
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of MSP58 inhibits the proliferation and metastasis in human renal cell carcinoma cells.
Zhai X; Wu Y; Zhang D; Chong T; Zhao J
Biomed Pharmacother; 2017 Jul; 91():54-59. PubMed ID: 28448870
[TBL] [Abstract][Full Text] [Related]
18. HDAC4 mediated LHPP deacetylation enhances its destabilization and promotes the proliferation and metastasis of nasopharyngeal carcinoma.
Sun X; Zhang K; Peng X; Zhou P; Qu C; Yang L; Shen L
Cancer Lett; 2023 May; 562():216158. PubMed ID: 37023940
[TBL] [Abstract][Full Text] [Related]
19. The histidine phosphatase LHPP: an emerging player in cancer.
Wu F; Ma H; Wang X; Wei H; Zhang W; Zhang Y
Cell Cycle; 2022 Jun; 21(11):1140-1152. PubMed ID: 35239447
[TBL] [Abstract][Full Text] [Related]
20. Expression and proliferation-promoting role of lymphoid enhancer-binding factor 1 in human clear cell renal carcinoma.
Shang D; Bi R; Han T; Wang D; Tian Y; Liu Y
Cancer Invest; 2014 Aug; 32(7):368-74. PubMed ID: 24897388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
